Fracture events in patients with primary biliary cholangitis during treatment with seladelpar in the phase III RESPONSE trial
Authors
- Sarah Proehl (ORCID: https://orcid.org/0009-0008-8255-3560)
- John M. Vierling (ORCID: https://orcid.org/0000-0001-5547-6020)
- Daria B. Crittenden (ORCID: https://orcid.org/0000-0002-8202-2072)
- Gideon M. Hirschfield (ORCID: https://orcid.org/0000-0002-6736-2255)
- Robert P. Kustra (ORCID: https://orcid.org/0000-0003-4491-9732)
- Xiangyu Liu (ORCID: https://orcid.org/0000-0002-1932-7199)
Institutions
- Baylor College of Medicine (US)
- Toronto General Hospital (CA)
- Gilead Sciences (United States) (US)